Former UFC Middleweight Champion Anderson Silva tested positive for anabolic steroids prior to competing against Nick Diaz at UFC 183, the UFC announced Tuesday.
Silva tested positive for both drostanolone and androstane in an out of competition drug test administered by the Nevada Athletic Commission on January 9th. Drostanolone is an anabolic steroid that helps the user increase muscle density and retain strength while losing weight. Androstane is a form of endogenous testosterone.
Silva will be given a temporary suspension by the NAC at their upcoming meeting on February 17th. He will then be scheduled to appear before the commission at a later date.
The UFC released the following statement on their website:
“On February 3, 2015, the UFC organization was notified by the Nevada State Athletic Commission that Anderson Silva tested positive for Drostanolone metabolites on his Jan. 9 out of competition drug test. UFC’s understanding is that further testing will be conducted by the Commission to confirm these preliminary results.
“Anderson Silva has been an amazing champion and a true ambassador of the sport of mixed martial arts and the UFC, in Brazil as well as around the world. UFC is disappointed to learn of these initial results.
“The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by its athletes.”
Below you will find a copy of Silva’s drug test results:
A big question raised by the results of the test is how Silva was allowed to compete while using these performance enhancing drugs. What is the point of doing out of competition drug testing if the results are not available until after the competition? This will likely be a topic of conversation at the next NAC meeting.
Continue to follow SciFighting.com as we will have all of the latest news regarding Silva’s failed drug test.